Walderez O Dutra1, Kenneth J Gollob. 1. Department of Morphology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. waldutra@gmail.com
Abstract
PURPOSE OF REVIEW: Chagas disease is a complex ailment caused by infection with Trypanosoma cruzi. It afflicts millions in Latin America. Years of studies have focused on the development of pathology in Chagas disease and recent studies have helped us understand the cellular mechanisms behind differential clinical evolution of Chagas disease. RECENT FINDINGS: We discuss recent findings concerning the cellular immune response in human Chagas disease focusing on immunoregulation and the development of pathology. We seek to put several findings into the context of a disease that initially controls an extreme and patent infection, and later progresses to a chronic phase marked by the presence (cardiac and digestive forms), or not (indeterminate form), of associated pathology. SUMMARY: Several theories exist to explain differential clinical evolution of Chagas disease. A coherent understanding of these theories will certainly aid in determining what combination of them approximates the true development of chagasic pathology. For achieving the goal of developing a successful therapy or intervention, it is critical that no theory be excluded at this point, but. Rather, rather that a thoughtful analysis and assimilation of the best components of each system into a central theory that best fits the reality of human Chagas disease is desirable.
PURPOSE OF REVIEW: Chagas disease is a complex ailment caused by infection with Trypanosoma cruzi. It afflicts millions in Latin America. Years of studies have focused on the development of pathology in Chagas disease and recent studies have helped us understand the cellular mechanisms behind differential clinical evolution of Chagas disease. RECENT FINDINGS: We discuss recent findings concerning the cellular immune response in humanChagas disease focusing on immunoregulation and the development of pathology. We seek to put several findings into the context of a disease that initially controls an extreme and patent infection, and later progresses to a chronic phase marked by the presence (cardiac and digestive forms), or not (indeterminate form), of associated pathology. SUMMARY: Several theories exist to explain differential clinical evolution of Chagas disease. A coherent understanding of these theories will certainly aid in determining what combination of them approximates the true development of chagasic pathology. For achieving the goal of developing a successful therapy or intervention, it is critical that no theory be excluded at this point, but. Rather, rather that a thoughtful analysis and assimilation of the best components of each system into a central theory that best fits the reality of humanChagas disease is desirable.
Authors: W O Dutra; O A Martins-Filho; J R Cançado; J C Pinto-Dias; Z Brener; G L Freeman Júnior; D G Colley; G Gazzinelli; J C Parra Journal: Int Immunol Date: 1994-04 Impact factor: 4.823
Authors: D D Reis; E M Jones; S Tostes; E R Lopes; G Gazzinelli; D G Colley; T L McCurley Journal: Am J Trop Med Hyg Date: 1993-05 Impact factor: 2.345
Authors: M de L Higuchi; P S Gutierrez; V D Aiello; S Palomino; E Bocchi; J Kalil; G Bellotti; F Pileggi Journal: Virchows Arch A Pathol Anat Histopathol Date: 1993
Authors: Rajendranath Ramasawmy; Kellen C Faé; Edecio Cunha-Neto; Susan C P Borba; Barbara Ianni; Charles Mady; Anna C Goldberg; Jorge Kalil Journal: Mol Immunol Date: 2007-06-04 Impact factor: 4.407
Authors: C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra Journal: Clin Exp Immunol Date: 2012-08 Impact factor: 4.330
Authors: Eva H Clark; Morgan A Marks; Robert H Gilman; Antonio B Fernandez; Thomas C Crawford; Aaron M Samuels; Alicia I Hidron; Gerson Galdos-Cardenas; Gilberto Silvio Menacho-Mendez; Ricardo W Bozo-Gutierrez; Diana L Martin; Caryn Bern Journal: Am J Trop Med Hyg Date: 2014-11-10 Impact factor: 2.345
Authors: Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues Journal: Infect Immun Date: 2019-07-23 Impact factor: 3.441
Authors: L S A Passos; L M D Magalhães; R P Soares; A F Marques; M do C P Nunes; K J Gollob; W O Dutra Journal: Clin Exp Immunol Date: 2017-07-03 Impact factor: 4.330
Authors: Ana-Carolina Oliveira; Bruna C de Alencar; Fanny Tzelepis; Weberton Klezewsky; Raquel N da Silva; Fabieni S Neves; Gisele S Cavalcanti; Silvia Boscardin; Marise P Nunes; Marcelo F Santiago; Alberto Nóbrega; Maurício M Rodrigues; Maria Bellio Journal: PLoS Pathog Date: 2010-04-29 Impact factor: 6.823
Authors: Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg Journal: Semin Immunopathol Date: 2012-10-18 Impact factor: 9.623